On Tuesday, former Packers football player, Brett Favre announced he suffers from Parkinson’s Disease. Parkinson’s Disease is ...
Bayer Ag BAYRY and its wholly owned subsidiary BlueRock Therapeutics LP announced positive 24-month data from an early-stage ...
A Parkinson’s Love Story” is told from the perspectives of the author as wife, mother, friend, perceptive memoirist and ...
Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease ...
Parkinson's disease a common but complex neurodegenerative disorder that affects 10 million people worldwide. Here are some ...
Researchers conducted a retrospective cohort study to compare the effects of SGLT-2 inhibitors and DPP-4 inhibitors on Parkinson disease risk among adults with T2D.
More than 20 years later, Alberts and a team of researchers have received a $3 million, five-year award from the National ...
The most impactful gene is the apolipoprotein E-e4 gene (APOE-e4) – people who carry two APOE-e4 copies have 12 times the ...
Swansea City AFC Foundation is launching walking football sessions for those affected by Parkinson’s disease, thanks to ...
The 16th-annual Great Salt Lick auction raised $19,000 on Sept. 21, with proceeds going to Parkinson's disease research at ...
A neurologist who treats and studies Parkinson's has a personal connection to the disease: Her father-in-law, who played in ...
The following is a summary of “SGLT2 Inhibitor Use and Risk of Dementia and Parkinson’s Disease Among Patients With Type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback